SCHEMBL5731352

SCHEMBL5731352

OC(c1ccccc1F)C1CO1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
CYP3A4 P08684 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
CYP2C9 P11712 1/20 0.37
OPRM1 P35372 1/20 0.34
OPRD1 P41143 1/20 0.34
OPRK1 P41145 1/20 0.34
OPRL1 P41146 1/20 0.34
IDO1 P14902 2/20 0.33
TDO2 P48775 2/20 0.33
PDE2A O00408 1/20 0.33
GAA P10253 1/20 0.33
CNR2 P34972 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17802367 0.78 CHRM2 (0.44) IDO1TDO2GAA
SCHEMBL17802365 0.78 CHRM2 (0.44) IDO1TDO2GAA
SCHEMBL29280848 0.77 ESR1 (0.41) CYP3A4ALDH1A1OPRM1OPRD1OPRK1
SCHEMBL8581474 0.77 CYP3A4 (0.34) CES2CES1CYP3A4MEN1KMT2A
SCHEMBL8579039 0.77 CYP3A4 (0.34) CES2CES1CYP3A4MEN1KMT2A
SCHEMBL8780966 0.77 CYP3A4 (0.34) CES2CES1CYP3A4MEN1KMT2A
SCHEMBL29591877 0.76 PDE2A (0.54) CES2CES1CYP3A4MEN1KMT2A
SCHEMBL5485147 0.76 PDE2A (0.54) CES2CES1CYP3A4MEN1KMT2A
SCHEMBL7299447 0.74 ALDH1A1 (0.46) KMT2AALDH1A1CYP2C9
SCHEMBL28927380 0.74 ALDH1A1 (0.36) MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1732887-A1 1-(1H-INDOL-1-YL)-3-(4-METHYLPIPERAZIN-1-YL)-1-PHENYL PROPAN-2-OL DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS OF THE NOREPINEPHRINE (NE) AND THE SEROTONINE (5-HT) ACTIVITY AND THE MONOAMINE REUPTAKE FOR THE TREATMENT OF VASOMOTOR SYMPTOMS (VMS) Wyeth (US) 2006-12-20 EP disclosed
WO-2005097744-A1 1-(1H-INDOL-1-YL)-3-(4-METHYLPIPERAZIN-1-YL)-1-PHENYL PROPAN-2-OL DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS OF THE NOREPINEPHRINE (NE) AND THE SEROTONINE (5-HT) ACTIVITY AND THE MONOAMINE REUPTAKE FOR THE TREATMENT OF VASOMOTOR SYMPTOMS (VMS) WYETH (US) 2005-10-20 WO disclosed